In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Columbus joins the states of Arkansas, California, Kansas, Kentucky, Minnesota and Mississippi and other cities and counties ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

A proposed Arkansas law would forbid pharmacy benefit managers (PBMs) from holding or acquiring interest in retail pharmacy ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.